CXCL12, in conjunction with its receptor, has been reported to promote pancreatic cancer development, invasion, and metastasis through the management of the tumor microenvironment via a complex crosstalk with other pathways (Sleightholm et al., 2017). Here, CXCL12 is linked to pancreatic neoplasm.